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Absence of glomerular injury or nephron loss in a normotensive rat
remnant kidney model. Severe reduction in renal mass (>50%) in the rat
uniformly results in progressive glomerular injury and loss of remnant
nephrons postulated to be due to increases in glomerular function
(hyperfiltration) and/or size (hypertrophy). Reduction in renal mass in
the rat also leads to the development of systemic and/or glomerular
hypertension. To examine the independent contributions of systemic
hypertension and glomerular hyperfiltration and/or hypertrophy to
progressive glomerular injury, a normotensive rat remnant kidney
model was developed in the Wistar-Kyoto (WKY) strain. Of the 34
WKY rats that underwent 5/6 nephrectomy, 25 remained normotensive
and without evidence of morphologic glomerular injury and/or nephron
loss for up to 14 to 16 weeks, despite glomerular hyperfiltration and
hypertrophy comparable to that previously observed in other rat
strains. Micropuncture studies at —six weeks after reduction in renal
mass demonstrated markedly increased SNGFR in remnant nephrons
of normotensive rats as compared to controls (66 7 vs. 25 4nI/mm,
P < 0.01), but glomerular capillary pressures (P0w) estimated from stop
flow pressures were only slightly increased (52.7 1 vs. 47.3 1 mm
Hg, P < 0.01). These data indicate that compensatory glomerular
hyperfiltration and hypertrophy after 5/6 nephrectomy may not lead to
progressive glomerular injury provided hypertension does not develop.
These data further suggest that in the absence of systemic hypertension,
increases in P0 required for adaptive hyperfiltration. may not be
sufficient to initiate progressive glomerular injury and nephron loss.
The compensatory biochemical, functional, and morphologic
changes that occur after an acute reduction in renal mass, have
generally been considered to be intially beneficial to the organ-
ism in minimizing the consequences of loss of functional renal
mass [1]. However, studies in the rat have demonstrated that
after a critical reduction in functional renal mass (>50%), the
previously normal remnant glomeruli and nephrons undergo
progressive injury over the ensuing several weeks to months
[2—81. By 12 to 16 weeks after 5/6 nephrectomy, 25 to 50% of the
remnant glomeruli exhibit glomerulosclerosis with associated
tubular atrophy and nephron loss [2—9]. The complex pathoge-
netic mechanisms responsible for the progressive glomerulo-
sclerosis after reduction in renal mass remain poorly under-
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stood and controversial [5, 7—21]. It has been proposed that
glomerular injury may be due to the increases in glomerular
capillary pressure and flow that mediate compensatory hyper-
filtration [8—10, 13]. Others have suggested that the progressive
glomerulosclerosis is an untoward consequence of structural
glomerular hypertrophy [17—201. A low protein diet has been
demonstrated to minimize the adaptive changes in both glomer-
ular structure and function and ameliorate the progressive loss
of remnant nephrons [3—10, 22, 23]. These observations have
led to the hypothesis that the adaptive changes in function
and/or structure after reduction in renal mass per se are
sufficiently maladaptive so as to be injurious to the remnant
nephrons [8—10, 17—20].
Severe reduction in renal mass in the rat is almost invariably
accompanied by the development of hypertension [3—5, 11—14,
16—20, 23—261. We have previously suggested that this co-
existent systemic hypertension may play a major role in the
pathogenesis of progressive glomerular injury in this model
[26]. This was based on the morphologic pattern of glomerular
injury and the demonstration of an impairment of the renal
autoregulatory mechanisms which normally protect against the
transmission of systemic hypertension to glomerular capillaries
[26—32]. The present studies were designed to determine if
adaptive increases in glomerular size and function after --5/6
reduction in renal mass would still result in progressive injury to
remnant glomeruli if the development of hypertension could be
prevented or minimized. The Wistar-Kyoto (WKY) strain was
selected because of its genetic resistance to the development of
hypertension [33, 34].
Methods
Renal ablation
Adult Male WKY rats weighing 240 to 375 g (Harlan) were
fed a standard diet (22% protein) and subjected to 5/6 ablation
(right nephrectomy and ligation of all but one posterior extra-
renal branch of the left renal artery) or sham ablation. Rats with
ablated and sham ablated kidneys were followed for 14 to 16
weeks before sacrifice to study the long term course or were
sacrificed at 4 to 6 weeks after micropuncture, autoregulatory
or morphometric studies. Morphologic studies were performed
on kidneys of all rats.
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Long term course
Rats with sham ablated (N = 9) or ablated kidneys (N = 12)
were followed with serial measurements of systolic blood
pressures in the awake, unanesthetized state. Serum creatinine
(Sr) and urinary protein excretion were measured at 4 to 6
week intervals for 14 to 16 weeks at which time the animals
were sacrificed and the kidneys processed for morphologic
studies after immersion fixation. Before sacrifice, the rats were
anesthetized with sodium pentobarbital (40 mg/kg i.p.) and the
GFR of the left kidney was measured by inulin clearance [241.
Micropuncture studies
These were performed in additional male WKY rats at --six
weeks after ablation or sham ablation. Left kidney GFR,
proximal tubular pressures (PT), stop flow pressures (PsF) and
SNGFR were measured as previously described [35]. The rats
were anesthetized with sodium pentobarbital (40 mg/kg i.p.) and
placed on a temperature regulated micropuncture table to
maintain body temperature at 37°C. Following tracheostomy,
indwelling polyethylene catheters (PE 50) were placed into onejugular and one femoral vein for infusion of solutions and
additional anesthetic. The left femoral artery was catheterized
to enable blood sampling and to continuously monitor the mean
systemic arterial pressure (AP), measured by an electronic
pressure transducer (Gould Model P23Db) and recorded on a
polygraph (Grass Instruments, Quincy, Massachusetts, USA).
The kidney was then placed in a lucite cup, warm agar was
dripped around the kidney to form a saline well; its surface was
illuminated with a fiberoptic light source and bathed with 0.9%
NaCl and the left ureter was catheterized. During the sugery, a
priming dose of inulin in 0.9% NaCI was administered followed
by a continuous infusion at a rate of 1.2 mI/hr calculated to
maintain a plasma inulin concentration of 50 to 100 mg/dl. The
proximal tubules were mapped by injection of small amounts of
0.9% NaCl stained with fast green dye using micropipettes with
a tip diameter of 4 to 6 sM. For determination of SNGFR, three
to five collections (1 to 3 mm) from proximal tubules were
obtained for determination of flow rate and inulin concentra-
tion. The aspiration rate was adjusted to maintain a column of
castor oil 3 to 4 tubule diameters in length, in a constant
position just distal to the site of puncture. Coincident with
tubular fluid collections, femoral arterial blood samples were
obtained for the determination of plasma inulin concentration.
Timed urine collections were used for calculation of GFR by
standard formulae. For measurement of SF' a pipette with a 12
to 15 sM tip diameter containing bone wax was inserted into the
middle convolution of a previously mapped proximal tubule and
a wax-block 3 to 4 tubule diameters in length was injected into
the tubule. A micropipette with a tip diameter of 3 to 4 LM
connected to a continuously recording servo-null micropressure
system was inserted into an early proximal tubule segment to
obtain PSF. At least 3 to 4 measurements were obtained during
each study.
Autoregulatory studies
These were performed in additional rats with ablated or sham
ablated kidneys at four to six weeks after surgery. The rats were
anesthetized with sodium pentobarbital (40 mg/kg i.p.), main-
tained at 37°C on a heated table, and surgically prepared to
assess for autoregulatory efficiency as previously described
[26]. In brief, a femoral vein was cannulated with polyethylene
tubing (PE-50) and a priming dose of inulin and p-aminohippu-
rate (PAH) in 0.9% mrs'i NaCl was administered, followed by a
continuous maintenance infusion of 0.9% m NaCI containing
inulin and PAH at 0.055 mI/mm aimed to maintain their plasma
concentration at —50 mg/dl and 2 mg/dl, respectively. A carotid
and a femoral artery, the contralateral femoral vein, and the left
ureter were then cannulated with polyethylene tubing. Mean
systemic arterial pressure (AP) and mean renal perfusion pres-
sure were continuously recorded through the carotid and fern-
oral artery transducers (Gould Model P-23Db). A hooked 27
gauge needle connected to a Silastic cannula was placed in the
left renal vein to measure PAH extraction. At the conclusion of
the surgery, a 0.9% NaCl bolus equal to 1% of body weight was
administered, followed by an infusion at 1.2 mI/hr for replace-
ment of surgical and ongoing losses. The common carotid
arteries were ligated after careful dissection and two 10 to 20
minute clearances of inulin and PAH were obtained at a renal
perfusion pressure of 130 to 150mm Hg and 110 to 130mm Hg.
The renal perfusion pressure was changed by an aortic mini-
clamp placed above or below the left renal artery as described
by Roman and Cowley [361. Blood samples were obtained at the
midpoint of each urine collection. After the clearance studies,
the remnant kidneys were removed for histological studies and
the animals were sacrificed by anesthetic overdose.
Morphometric studies
Morphometric measurements of glomerular hypertrophy
were performed at four weeks after surgery in rats with ablated
or sham ablated kidneys. The rats were anesthetized with
sodium pentobarbital (40 mg/kg i.p.), the aorta was cannulated
and the kidneys were perfusion-fixed at the measured mean
arterial pressure. Following a brief perfusion with saline
(38.5°C) until the venous effluent cleared, perfusion with 2%
wt/vol paraformaldehyde and 2.5% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.4 (38.5°C) was continued for ten
minutes. The kidneys were excised and sliced at 2 mm intervals
in the transverse plane. Random sections of well-perfused,
unscarred cortex were selected and oriented with one edge at
the capsular surface and one edge at the cortico-medullary
junction, beneath the arcuate arteries. To preserve orientation,
the sections were flat-embedded in plastic and 1 pm thick
complete sections were cut with glass knives and stained with
toluidine blue [25]. The morphometric analysis was restricted to
superficial and midcortical glomeruli in order to correlate these
measurements to the data obtained by micropuncture. There-
fore, all glomerular profiles except for the juxtamedullary gb-
meruli were evaluated by standard stereologic methods [37, 38].
The maximum and minimum individual glomerular diameters
(between the internal edges of Bowman's capsule) were mea-
sured by an ocular with concentric circles calibrated with a
stage micrometer. As the ratio of these diameters was below the
limit of 1.4, proposed as the highest values that allows the
treatment of ellipsoids as spheres [37, 38], the geometric mean
of the major and minor axis measurements was considered to be
the diameter of each individual glomerulus. The real distribu-
tion profile of the different glomeruli in each animal was then
determined by the method of van Damme and Koudstaal [39].
The mean glomerular diameter for each animal was calculated
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from the distribution profile and glomerular volume was calcu-
lated from the formula 4/3 r r3. The contribution of glomerular
capillary enlargement to the glomerular hypertrophy response
was determined morphometrically by standard point counting
techniques [37, 38]. Twenty glomeruli were selected in each
animal. The selected glomeruli included the hilar area and were
therfore felt to represent a complete cross section close to the
center of the glomerulus. The validity of this selection is
supported by the fact that the mean glomerular diameter for the
glomeruli selected for point counting was not significantly
different from the mean glomerular diameter estimated from the
real distribution profile of all the cortical glomeruli in the
sections. The total glomerular profile cross-sectional area was
calculated from the total number of points overlying the entire
glomerular tuft. The capillary lumina component was repre-
sented by the points overlying the empty spaces inside the
capillaries. Between 800 and 1000 capillary profiles were
counted in the twenty glomeruli from each rat and used to
calculate the absolute mean volume of the capillary lumina. The
number of transections of capillaries per unit area of glomerulus
was counted and multiplied by two to yield the length of
capillary ioops per unit of glomerular volume [37, 40]. Dividing
the luminal volume of capillaries by their length equals the
mean cross-sectional area of glomerular capillaries perpendic-
ular to the long axis [37]. Mean capillary radii were then
calculated by the formula mean cross-sectional area = ir r2.
Morphologic studies
A transverse section of the kidney through the papilla was
fixed in 10% neutral buffered Formalin and embedded in par-
affin. Sections were cut at 4 m and stained with hematoxylin
and eosin, periodic acid-Schiff, Masson's trichrome, and phos-
photungstic acid hematoxylin stains. Sections were evaluated
systematically in each kidney for glomerular and vascular
lesions as described previously [25, 26]. One to four hundred
glomeruli were present in such sections and all the glomeruli in
individual sections were evaluated.
Systolic blood pressures (SBP) were measured with an oc-
clusive tail cuff (model B60 type sensing cuff, amplified by an
1 1TC model 59 amplifier from Life Sciences, Landing, New
Jersey, USA), and recorded with a Bausch and Lomb, Omni-
scribe Recorder (Houston Instruments, Austin, Texas, USA).
This procedure was performed in a warm quiet room on trained,
restrained unanesthetized animals and yielded reproducible
readings. Serum cretinine was measured by an autoanalyzer
(Beckman Instruments). Urinary protein was measured by
quantitative sulfosalicylic acid with human serum albumin
serving as standard. Inulin and PAH concentration in urine and
plasma filtrates were determined spectrophotometrically by the
diphenylamine and ethylenediamine methods as previously
described [26]. For micropuncture studies, tubular fluid volume
was determined with a constant bore capillary tube and a slide
comparator (Gaertner Scientific Corp., Chicago, Illinois, USA).
Tubular fluid inulin concentration was determined in duplicate
by a modification of the fluorometric method of Vurek and
Pegram [41]. The plasma protein concentration was determined
by refractometry. SNGFR, glomerular filtration rate (GFR) and
renal plasma flow (RPF) were calculated using standard formu-
lae, and glomerular capillary pressure (P0) was estimated as
the sum of SF and colloid oncotic pressure calculated from the
total plasma protein concentration.
All results are mean SEM. Statistical analysis was per-
formed using ANOVA and Student t-test for paired and un-
paired data with Bonferroni correction where appropriate [42].
A P value of >0.05 was considered non-significant.
Results
A total of 26 rats with sham ablation and 34 rats with 5/6 renal
ablation were investigated. Of the 34 rats who underwent 5/6
ablation, 25 rats stayed normotensive throughout their course
ranging from 4 to 16 weeks after renal ablation, while nine
developed systemic hypertension during the follow-up period.
For the purposes of this study, a SBP of >150 mm Hg was used
to separate hypertensive from normotensive WKY rats after
ablation, as the SBP in sham-operated controls never exceeded
150 mm Hg. The body weight, systolic blood pressure (SBP),
5Cr and urine protein excretion data for the sham operated
controls and the normotensive and hypertensive rats with renal
ablation is presented in Table 1.
Results in ablated normotensive rats
In the normotensive ablated groups, the and 24-hour
urine protein excretion increased significantly by 4 to 6 weeks.
The 10 rats that were followed for 14 to 16 weeks after 5/6 renal
ablation maintained similar SBP and SCr values throughout
their course. However, 24-hour urinary protein excretion
showed a further significant increase during this same time
course (P < 0.05, paired t-test).
The micropuncture data obtained in six sham operated and
six normotensive ablated rats at six weeks after ablation, is
presented in Table 2. The remnant nephrons of normotensive
WKY rats after 5/6 ablation demonstrated marked increases in
single nephron glomerular filtration rate (SNGFR) compared to
sham operated controls, 66.2 6.9 nI/mm versus 25.4 3.9
ni/mm, P < 0.01. Despite the two-and-a-half-fold increase in
SNGFR, glomerular capillary pressures (Gc) as estimated
from stop-flow pressures were only mildly elevated as com-
pared to sham ablated rats (52.7 1.3 vs. 47.3 1.1 mm Hg, P
<0.01).
Figure 1 demonstrates the differences in autoregulation of
renal plasma flow (RPF) and glomerular filtration rate (GFR)
between six sham operated rats and five normotensive rats with
remnant kidneys. The sham operated rats exhibited normal
renal autoregulation when the mean arterial pressure (AP) was
altered between 100 and 150 mm Hg. The mean value for RPF
and GFR at AP of 118 1 mm Hg were 97.6% and 96%,
respectively, of the values of RPF and GFR at AP of 139 2
mm Hg. In contrast, the rats with remnant kidneys demon-
strated impaired autoregulation of RPF and GFR in response to
a similar change in AP. The mean RPF and GFR in these rats at
118 3 mm Hg was 63.1% and 61.7%, respectively, and
significantly different from the values at 144 4 mm Hg (P <
0.01, paired t-test).
The most important morphologic finding in the present study
was the remarkable preservation of renal structure in the WKY
rats, which remained normotensive after —5/6 renal ablation.
Fourteen to sixteen weeks after ablation, all of the remnant
kidneys had developed a marked degree of compensatory
hypertrophy. In spite of the ligation of 2/3 of the extrarenal
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Table 1. Course of remnant kidney model in male WKY rats
Pre-ablation
Post-ablation
4-6 Weeks 14—16 Weeks
SBP
mm Hg
SCr
mg/dl
U prot
mg/24 hr
SBP
mm Hg
SCr
mg/d!
U prot
mg/24 hr
SBP
mm Hg
SCr
mg/d!
U prot
mg/24 hr
Sham ablatedd
(N = 26)
pre-ablation
body wt
292 7 g
Ablated
normotensive
(N = 25)
pre-ablation
body wt
299 8 g
Ablated
hypertensive
(N = 9)
preablation
body wt
280 8 g
123 2.2
126 2.1
123 4.7
0.51 0.02
0.46 0.02
0.53 0.04
10.7 0.6
9.5 0.6
8.9 1.0
127 2.9
130 2.5
161
0.52 0.02
0.99 O.O3at
1.15 003a.b.c
10.6 0.6
17.8 I.6'
30.9 7.2c
133 3.8
130 4.0
0.58 0.02
0.98 005a,b
11.8 1.2
31.5 45a.b
The GFR (mi/mm/kg) of the left kidney measured before sacrifice for morphologic studies at 14-16 weeks were sham — 2.8 0.34 (N = 6),
normotensive ablated — 1.93 0.34 (N = 8), and the two hypertensive ablated rats 0.53 and 0.95.
All results in this and subsequent tables are mean SEM.
a Significantly different from pre-ablation values, P < 0.05
b Significantly different from sham, P < 0.05
Significantly different from normotensive ablated, P < 0.05
d The values at 14—16 weeks are for 9 sham ablated rats
e The values at 14—16 weeks are for 10 normotensive ablated rats
The SBP, S. and U prot values for the 2 hypertensive rats that were followed for 14—16 weeks were 165 and 190 mm Hg, 2.7 and 2.0 mg and
54.4 and 32.4 mg, respectively
Table 2. Micropuncture studies at 6 weeks
A1
mm Hg
GFR
tnl/min/kg
SNGFR SF
nI/mm
PUC
mm Hg
Sham ablated
(N =6)
117.9 4.1 2.6 0.4 25.4 3.9 32.9 1.0 14.6 0.6 47.3 1.1 12.1 0.8 35.3 1.8
Ablated normotensive 123.8 1.5 1.8 0.3 66.2 6.9a 37.8 l.Oa 15.1 0.5 52.7 l.3a 12.0 0.7 40.7 1.6"
(N=6)
Abbreviations are: AP, mean arterial pressure; SNGFR, single nephron GFR; SF, Stop flow pressure; TA, plasma oncotic pressure; P0,,
glomerular capillary pressure; T, proximal tubular pressure; P, transcapillary hydraulic pressure difference.
a p < 0.01, bp < 0.05, compared to sham ablation
branches of the left renal artery, the remnant kidneys were
often as large or larger than a single kidney from a sham
operated control. Although the remnant kidneys had a small
depressed scar and some distortion of the renal outline as a
residual of the initial infarct, most of the cortical surface was
smooth and unscarred. Hypertrophy was also apparent on
microscopic examination where dilated, enlarged tubules were
seen (Fig. 2A) when compared to the controls (Fig. 2B). In
addition to the obvious increase in tubular dimensions, the
tubular cells manifested signs of hyperplasia. These included
clustering of tubular nuclei (Fig. 3A), prominent nucleoli,
hyperchromaticity of nuclei, and cytoplasmic basophilia. Tubu-
lar proliferation was also evidenced by extension of proximal
tubular cells into Bowman's capsule where they replaced the
flattened cells of the parietal epithelium in lining Bowman's
space (Fig. 3B). The glomeruli were widely separated and
apparently reduced in number, but this was not due to nephron
drop-out in the remnant kidney where there were no atrophic
tubules, foci of interstitial fibrosis, or hyalinized glomeruli. The
glomeruli were obviously enlarged (Fig. 4A) compared to
controls (Fig. 4B), and they had histological abnormalities
which included increased PAS-positive mesangial matrix, di-
lated capillaries, and PAS positive droplets in the glomerular
epithelial cells. Despite the presence of the above abnormali-
ties, there was a striking absence of glomerular scarring (either
global or segmental), hyalinosis, and glomerular or vascular
necrosis (Table 3). Essentially the same pattern of morphologic
changes was observed in normotensive animals at 4 to 6 weeks
after ablation. These animals also exhibited compensatory
hypertrophy as evidenced by tubular dilatation and hypertro-
phy with glomerular enlargement. There was no evidence of
glomerular or tubular drop-out. The one micron thick, plastic
embedded sections confirmed the presence of enlarged glomer-
uli, dilated glomerular capillaries, and mesangial expansion and
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Fig. 1. Effect of changes in mean arterial
pressure (AP) on renal plasma flow (RPF) and
glomerular filtration rate (GFR) within the
autoregulato,y range in 6 rats with sham ablated
(interrupted lines) and 5 normotensive rats with
— 1 ablated kidneys (solid lines). The changes in RPF
and GFR in sham ablated rats were not
—
statistically significant (The mean values at AP of
118 1 mm Hg were 97.6% 4.5% and 96.0
6.4%, respectively, of the values at 139 2 mm
Hg). In the ablated group, similar changes in AP
resulted in significant changes in RPF and GFR
(The mean values at AP of 118 3 mm Hg were
63.1 4.9% and 61.7 11.1%, respectively, of
the values at AP of 144 4 mm Hg; P < 0,01).
provided additional morphologic detail (Fig. SA). The glomer-
ular epithelial cells appeared enlarged and active with promi-
nent nucleoli, increased basophilic cytoplasm, cytoplasmic
vacuoles and attenuated, cytoplasmic processes (Fig. 5B).
These latter changes have suggested separation of the GEC
from the basement membrane, but this diagnosis cannot be
made by light microscopy and requires ultrastructural confir-
mation. The morphometric data obtained from four normoten-
sive ablated and five sham ablated rats where kidneys were
perfusion fixed at their measured mean arterial pressure and
plastic embedded is presented in Table 4. The appearance of
glomerular hypertrophy was confirmed by measurement of
glomerular diameters and volumes which were significantly
greater in the remnant kidneys than in their controls. Glomer-
ular capillary enlargement was present in all animals studied
morphometrically. The mean glomerular capillary volumes,
length and radii were significantly greater in the glomeruli of
rats with remnant kidneys.
Results in ablated hypertensive rats
The minority of WKY rats (9 of 34) which developed sys-
temic hypertension after 5/6 renal ablation demonstrated similar
but significantly greater increases in and protein excretion
at 4 to 6 weeks after ablation (Table 1). Two of these nine
hypertensive rats were followed for 14 to 16 weeks. These rats
demonstrated progressive increases in the serum creatinine and
urinary protein excretion (Table 1, legend), as has been re-
ported for other rat strains.
The morphologic findings in the remnant kidneys of hyper-
tensive rats were distinctly different from those of normoten-
sive rats. Rats that developed systemic hypertension had neph-
ron drop-out as evidenced by focal glomerular ischemia, tubular
atrophy and interstitial fibrosis scattered between islands of
surviving hypertrophied nephrons (Fig. 6). In addition to the
glomerular hypertrophy similar to that observed in the nor-
motensive rats, there were definitive glomerular lesions (Table
3). At 14 to 16 weeks after 5/6 nephrectomy, the glomerular
lesions were most frequently segmental scars (Fig. 7A), but
acute, destructive lesions were also seen. Qualitatively similar
glomerular pathology was observed in 4/7 hypertensive rats
who were followed for 4 to 6 weeks. The acute pattern of
glomerular injury was characteristic of malignant hypertension
with fibrinoid necrosis, capillary thrombosis, and exudation of
fibrin with occasional crescent formation in the glomeruli (Fig.
7B). This pattern of glomerular injury was observed in 2 to 10%
of glomeruli. Segmental and/or global glomeruloscierosis was
also seen in 2 to 5% of the glomeruli of the hypertensive rats at
4 to 6 weeks but was not observed in the absence of active
glomerular injury. Focal hypertensive vascular injury of the
arterioles was also observed in 3/9 hypertensive rats.
Discussion
In the present study, the functional and structural changes
after 5/6 nephrectomy were characterized in adult WKY rats
who stayed normotensive throughout their course. A similar
detailed characterization was not performed for WKY rats who
developed hypertension after subtotal nephrectomy, both be-
cause of the low incidence of hypertension and because our
specific objective was to evaluate the responses to 5/6 nephrec-
tomy in the absence of hypertension. Twenty-five of 34 adult
A B
525
15
5—
E
U-
a.
+ +
120
I I
140 120 140
Mean arterial pressure, mm Hg
Bidani et a!: Normotensive remnant kidney model 33
Fig. 2. Low power photograph of a WKY rat
kidney 14 to 16 weeks after surgery. A.
Remnant kidney from a normotensive WKY
rat. There are dilated tubules, and the number
of glomeruli in this subcapsular area is
reduced. Note the absence of interstitial
scars, tubular atrophy and glomerular
obsolescence. B. Sham operated WKY
control. Note the normal renal architecture,
the tubular dimensions and the number of
glomeruli compared to A. A and B, Jones'
stain, x80.
male WKY rats remained normotensive after 5/6 reduction in
renal mass, and exhibited a striking preservation of renal
morphology for up to four months after ablation. Unlike the
previous studies in other rat strains after 5/6 nephrectomy,
there was no morphologic evidence of progressive glomerular
injury or nephron loss [2—7, 11—14, 16—201. Serial measurements
of renal function (Sr and GFR) failed to demonstrate a deteri-
oration with time. The Sr after ablation remained essentially
unchanged in normotensive rats between the fourth week and
time of sacrifice at 14 to 16 weeks after ablation. Similarly the
GFR at the time of sacrifice (14 to 16 wks) in the normotensive
ablated rats was not significantly different from the values
obtained in the normotensive rats at —six weeks after ablation.
Since these remnant kidneys demonstrated comparable glomer-
ular hypertrophy and hyperfiltration to that observed in other
strains after —5/6 nephrectomy [6, 8, 13, 16—19], the data
demonstrate that these adaptive changes are not necessarily
injurious when they occur in the absence of systemic hyperten-
sion. These data in the normotensive WKY rats indicate that
the development of systemic hypertension and/or glomerular
injury may not be a universal and inevitable feature of —5/6
reduction in renal mass.
The micropuncture data in normotensive rats provide one
possible explanation for the lack of glomerular injury in nor-
motensive rats with remnant kidneys. Several studies have
suggested that glomerular capillary hypertension is a major
pathogenetic mechanism for glomerular injury [5, 9, 13, 14, 43].
In the present study, only modest elevations of GC of —5 mm
Hg were seen in normotensive rats with remnant kidneys. This
is in contrast to the more severe elevations of P0 which have
been observed after subtotal nephrectomy in previous studies in
other rat strains and which are associated with progressive
glomerular injury [6, 8—10, 13, 14, 43, 44]. Presumably, these
relatively mild increases of Gc in normotensive rats in the
present study are insufficient to initiate progressive glomerular
injury. Apparently, the more severe and pathogenetically sig-
nificant glomerular capillary hypertension that has been ob-
served in other rat strains after ——5/6 nephrectomy represents
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Fig. 3. Remnant kidney, normotensive WKY rat, 14—16 weeks post-
ablation. A. In a segment of the tubule (arrow) the nuclei are clustered,
the nucleoli are prominent and the cytoplasm is basophillic. 13. Cuboidal
cells at the tubular pole of Bowman's capsule are replacing Bowman's
squamous parietal epithelium. x275. Inset. A mitotic figure (arrow)
indicates proliferative activity in this epithelium. Glomerulus - G. X440.
A and B. Hematoxylin and Eosin (H and E).
the transmission to the glomerulus of the co-existent systemic
hypertension that develops in these rat strains. Such an inter-
pretation is supported by the demonstration that autoregulatory
mechanisms which normally prevent such transmission in intact
kidneys, are impaired in remnant kidneys [5, 26-31, 46]. The
decrease in Gc that is usually observed in such remnant
kidneys after pharmacologic or mechanical reduction in sys-
temic blood pressure provide further support for this concept
[9, 13, 45, 46]. A similar impairment of renal autoregulatory
ability was noted in the remnant kidneys of normotensive WKY
rats in the present study, as has been previously describd in
other strains [5, 26, 31, 46], thus excluding preserved renal
autoregulatory ability as an explanation for the lack of glomer-
ular injury in normotensive rats. Additionally, the data in the
normotensive WKY rats indicate that the preglomerular vaso-
dilation and impaired autoregulation observed after subtotal
nephrectomy may not be sufficient to result in severe glomeru-
lar hypertension and injury in the absence of systemic hyper-
tension. However, Anderson et a! were unable to normalizeP and prevent glomerular injury despite apparent control of
systemic hypertension with a triple drug regimen (hydralazine,
reserpine and hydrodiuril [13]). Triple drug therapy in their
4—6 weeks 14-16 weeks
post-ablation post-ablation
Normo- Hyper- Normo- Hyper-
tensive tensive tensive tensive
Number of rats 15 7 10 2
Ratswith 0 4 0 2
glomerular
injury
Mean % glomeruli 0 7% 0 11%
with injury
study was associated with further preglomerular vasodilation
and relative efferent vasoconstriction, so that GC was not
reduced. These data suggest that antihypertensive regimens
may differ in their ability to lower and prevent injury,
presumably because of their independent hemodynamic effects
on the renal vasculature.
Other recent studies have suggested that glomerular hyper-
trophy rather than glomerular capillary hypertension is the
major determinant of glomerular injury and sclerosis [17—20,
47]. In some studies a poor correlation between measured P0c
and glomerular injury was observed, but better correlation was
Fig. 4. The glomeruli of the remnant kidneys from the normotensive
WKY rats 14 to 16 weeks post-ablation (A) appear larger than the
glomeruli of the sham operated controls (B). A and B. Jones' stain,
x275.
Table 3. Morphologic glomerular injury after ablation
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Table 4. Morphometric studies
D0
p.m
V0
xJO-6 jim3
FVp
% JO
Vcp
p.m3
CSAc
jim2 mm
R,p
jim
Sham ablated (N = 5) 147.4 3.2 1.68 0.11 28.1 1.0 474 44.0 44.4 3.9 10.81 0.9 3,74 0.16
Ablated normotensive 183.8 5.8 3.26 0.31a 28.3 1.6 909 46.la 66.9 l.6a 13.58 0.60" 4.61 0.06
(N = 4)
Abbreviations are: D0, mean glomerular diameter; V0. glomerular volumes; fractional capillary volume; V,p, capillary lumen volume;
CSACP, mean capillary cross sectional area; mean capillary length; capillary radius.
a p < 0.005, b P < 0.05 compared to sham
Fig. 5. Remnant kidney, normotensive WKY, 4 to 6 weeks post-
ablation. A. Morphometric studies were performed on kidneys perfu-
sion fixed at the measured arterial pressure. The capillaries are patent
and frequently dilated. The mesangial matrix is increased, and more
morphologic detail is apparent (compare with Fig. 4A). x275. B. The
mesangial areas are expanded by matrix. The epithelial cells are
occasionally prominent (asterisk) and have frequent vacuoles, reab-
sorption droplets and elongated cytoplasmic processes (arrow). >(700.
A and B. Toluidine blue.
demonstrated between glomerular hypertrophy and glomerulo-
sclerosis [16—20J. Our data indicate that glomerular hypertrophy
per se may not be a sufficient condition for progressive glomer-
ular injury in the absence of systemic and/or glomerular hyper-
tension. Nevertheless, glomerular hypertrophy may contribute
to an increased vulnerability of remnant glomeruli to injury if
glomerular capillary wall tension rather than glomerular pres-
sure is the significant pathogenetic factor in glomerular injury.
The Laplace law predicts that the impact of increases in
glomerular capillary pressures will be magnified by an increase
in the glomerular capillary radii (T = P x R, where T is wall
tension in dynes/cm, P is transmural pressure in dynes/cm2 and
R is radius in cm) [48]. This is illustrated in Figure 8. A
significant increase in glomerular capillary radii has been noted
both in the present and previous studies after reduction in renal
mass [37, 49]. Thus, glomerular capillary hypertrophy and
impaired preglomerular autoregulation may synergistically con-
tribute to an increased vulnerability to glomerular injury of
remnant nephrons, when hypertension is present. The protec-
tion against progressive glomerular injury, provided by thera-
peutic interventions that prevent systemic and/or glomerular
hypertension, decrease glomerular hypertrophy, or preserve
renal autoregulation, is consistent with such a concept [5—14,
26].
It is possible that the lack of glomerular injury in the majority
of WKY rats reflects differences in genetic susceptibility to
glomerular injury and sclerosis [34]. The WKY strain has been
noted to be resistant to the development of proteinuria and
glomeruloscierosis that is seen with aging in most rat strains
[33, 34]. However, WKY rats with remnant kidneys that
became hypertensive displayed the characteristic functional
and morphologic course that has been described in untreated
rats of other strains with remnant kidneys [2—14, 16—20]. The
reason for the development of systemic hypertension and
glotnerular injury in ——25% ofadult WKY rats after 5/6 ablation
cannot be definitively inferred from these studies. This may be
due to genetic heterogeneity within the WKY strain, or it may
be that these rats underwent a greater than 5/6 reduction in
renal mass, due to differences in the vascular supply pattern of
the ablated kidneys, despite the renal ablation having been
performed in a uniform manner. The slightly (0.16 mg/dl) but
significantly higher S. in hypertensive rats as compared to
normotensive rats at 4 to 6 weeks after ablation may be a
reflection of this phenomenon or may be due to the significant
glomerular injury that had already occurred in these kidneys.
These data in hypertensive rats suggest that the resistance of
the adult WKY strain to hypertension and glomerular injury
may not be absolute. Conceivably a greater reduction in renal
mass could increase both the incidence of systemic hyperten-
sion and glomerular injury. However, —5/6 reduction in renal
mass was achieved in normotensive WKY rats as indicated by
the typical increases in SNGFR, SNGFR to GFR ratio, and
glomerular hypertrophy comparable to that observed in other
rat strains after 5/6 reduction in renal mass [5, 13, 18, 20, 49]
without resulting in progressive glomerular injury or nephron
loss. Moreover, even a lesser degree of renal mass reduction
(40%) when produced by ligation of renal artery branches as
done in the present study, is associated with both the develop-
ment of systemic hypertension and glomerular injury in other
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Fig. 6. Remnant kidney, hypertensive WKY
rat, 14 to 16 weeks post-ablation. Focal
nephron loss is indicated by foci of tubular
atrophy, interstitial fibrosis and shrunken
ischemic glomeruli (arrows) surrounded by
hypertrophied glomeruli and tubules. Jones'
stain, x80.
Fig. 7. Glomerular lesions in a remnant kidney of a hypertensive WKY
rat. A. Fourteen to 16 weeks post-ablation. A segmental scar has
obliterated the capillary architecture in 40 percent of the tuft, and there
is a broad adhesion to Bowman's capsule. B. Four to 6 weeks
post-ablation. Acute glomerular lesion with endothelial swelling, focal
capillary thrombosis and a large mass of fibrin in the urinary space. A.
and B. H and E, x275.
rat strains [44], thus supporting the importance of systemic
and/or glomerular hypertension to this lesion.
The pattern of morphologic injury to the glomeruli observed
in the hypertensive animals in the present study also supports a
hypertensive basis for these glomerular lesions. Two types of
morphologic lesions were observed in the present study (a)
acute active injury which was more predominant at 4 to 6 weeks
after ablation and (b) glomerulosclerosis which was dominant at
14 to 16 weeks after ablation. The acute active lesions have
previously been described after subtotal nephrectomy [4, 6, 11,
12, 24—26] and are indistinguishable from those described in
other experimental models of hypertension [31, 50—54]. On the
other hand, the precise pathogenesis of the lesion of focal
glomerulosclerosis in the remnant kidney model has not been
completely established. Although the lesion occurs in many
glomerular diseases, it has been consistently observed in exper-
imental hypertension [31, 50—54]. As segmental and/or global
glomerulosclerosis in the present study was only observed in
remnant kidneys also exhibiting active glomerular injury, it is
likely that the focal glomerulosclerosis observed in our study
represents at least in part, a later chronologic stage in the
morphologic evolution of active acute hypertensive injury.
Such an evolution of acute hypertensive injury to glomerulo-
sclerosis has been previously described in both experimental
hypertension and in remnant kidneys [4, 50, 54]. It is also
possible that less severe hypertensive injury to some glomerular
capillaries may directly evolve to lesions of focal glomerulo-
sclerosis without an intermediate phase of acute active injury.
A recent review of the pathology of glomerular lesions in the
renal ablation model has also concluded that the glomerular
lesions seen in experimental hypertension and after renal abla-
tion appear identical and probably arise through similar mech-
anisms [5]. It is conceivable that alteration of some glomerular
cell function secondary to 5/6 ablation may directly contribute
to focal glomerulosclerosis. However, it appears that an inter-
action with increased systemic and/or glomerular pressures is
probably required, as the lesions were not observed in nor-
motensive rats. Thus, these data imply that the resistance to the
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Capillary radius, pm
Fig. 8. An illustration of the synergistic effects of changes in transcap-
illary hydrostatic pressure difference ( p mm Hg) and mean glomer-
u/ar capillary radius (pm) on the calculated capillary wall tension
(dynes/cm).
development of progressive glomerular injury in WKY rats
resides in their resistance to the development of systemic
hypertension. This does not exclude the possibility that suscep-
tibility to the development of progressive glomerulosclerosis
may vary among species and/or strains of animals, despite
comparable elevations of GC This variable susceptibility may
be due to differences in other postulated pathways for glomer-
ular injury [5,7, 15, 16, 21, 34, 55, 56].
Although active morphologic injury and glomeruloscierosis
were not observed in the normotensive WKY rats, significant
proteinuria did occur. These observations suggest that the
pathogenetic mechanisms for proteinuria may not be identical
to those responsible for progressive glomerulosclerosis. Our
findings are in accord with the micropuncture observations of
Yoshioka et al, in this model, which demonstrate that the bulk
of proteinuria occurs primarily from structurally intact glomer-
uli [451. The mechanisms responsible for this proteinuria remain
to be defined. Since a low protein diet is successful in prevent-
ing both hyperfiltration and proteinuria [5, 6, 8—10], the avail-
able evidence implies a hemodynamic basis. One may postulate
that mild increases in glomerular capillary pressure and/or wall
tension are sufficient to result in proteinuria [45] but morpho-
logic evidence of glomerular injury requires a more marked
elevation of transmitted systemic pressures.
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